BOSTON, MA -- (MARKET WIRE) -- January 23, 2007 -- Solos Endoscopy, Inc. (PINKSHEETS: SLSY) announced today that the Company has launched worldwide its new Solos Breast Endoscopy System. Solos Endoscopy will roll out the system to hospitals and doctors throughout the world. The Solos Breast Endoscopy System is ideal for performing Mammary Ductoscopy procedures, which allows physicians to examine the mammary ducts under direct visualization. Clinical studies have shown that Breast Endoscopy (Mammary Ductoscopy) is capable of visualizing lesions consistent with ADH and early stages of cancer at dramatically smaller sizes than is currently possible through mammography. With the Solos System, physicians worldwide can find breast cancer and precancerous breast lesions as small as 0.2mm in diameter. This is 25 times smaller than is typically seen on a standard mammogram. This means the tumor can be found up to 5 years earlier -- while still confined within the mammary ducts where treatment survival rates of 99% have been reported. The Company will be posting information on the new system on their website at www.solosendoscopy.com.
